GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

BioQuest BQST · USD

N/A · US listing · 🇺🇸 United States

Compare

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2026

Revenue

$178,564

FY2014FY2026

Net income

−$905,054

FY2014FY2026

Free cash flow

−$300,430

FY2014FY2026

Shareholders' equity

−$1.1m

FY2014FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2014
Revenue$178,564$144,376————————
Gross profit$69,042$41,924——−$468−$1,408−$164——−$648
Research and development$56,573$103,797————————
Operating income−$838,049−$828,779−$90−$49,063−$817,920−$2.2m−$356,554−$2,175−$2,180−$252,000
Net income−$905,054−$781,400−$123−$140,664−$721,408−$2.4m−$361,504−$2,175−$2,175−$616,000
Diluted earnings per share-0.30-0.03-0.00-0.01-0.06-0.21-0.04-0.01-0.00-8.58

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2014
Total assets$1,652$1.1m$5,914$31$33,540$17,097$166——$889,903
Cash and short-term investments$1,652$2,079$5,914$31$33,540$260$166——$543,853
Total liabilities$1.0m$910,361$632,896$553,685$466,530$1.8m$138,745$8,820—$14,700
Debt$383,595$388,102$183,300$183,300$183,300$74,202$40,000———
Shareholders' equity−$1.1m$201,718−$626,982−$553,654−$432,990−$1.8m−$138,579−$8,820—$875,203
Shares outstanding3m30m12m11m11m11m8m0m3m0m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2014
Cash from operations−$300,427−$746,239−$62,689−$53,509−$116,720−$193,206−$124,834$2—−$600,340
Capital spending−$3————−$4————
Free cash flow−$300,430−$746,239−$62,689−$53,509−$116,720−$193,210−$124,834$2—−$600,340

Latest quarters

By quarter end

Jul 2026Apr 2026Jan 2026Oct 2025Jul 2025Apr 2025Jan 2025Oct 2024
Revenue$24,592$18,506$82,481$58,872$18,706$144,376——
Gross profit$18,092$368,525−$222,251$43,982−$121,214$41,924——
Operating income−$8,145−$110,836−$429,239−$52,759−$245,215−$698,610−$97,414−$17,506
Net income−$21,045−$131,344−$442,369−$72,053−$259,394−$625,761−$105,904−$25,996
Diluted earnings per share-0.01-0.04-0.15-0.00-0.01-0.02-0.00-0.00
Total assets$3,807$1,652$29,500$59,323$82,614$1.1m——
Cash and short-term investments$3,807$1,652—$4,323$114$2,079——
Debt$388,395$383,595$383,595$383,595$388,102$388,102——
Shareholders' equity−$1.1m−$1.1m−$971,992−$929,624−$1.1m$201,718——

Growth per year

Compound annual rate

3 years5 years10 years
Operating income157.5%-17.6%58.7%
Net income86.0%-17.5%59.9%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin34.4%———
Operating margin-516.1%———
Net margin-522.2%———

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Price to earnings-0.8-19.6-48735.8-9.2-0.2-0.0-0.1-2.8-11.7
Price to sales4.2105.8———————

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return-0%354%1370%115%5%-100%49900%0%0%0%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 2000-to-1 reverse split · 15 Nov 2019
  • 10-for-1 split · 23 Jun 2014

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.